Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.
2.

JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Larena M, Prow NA, Hall RA, Petrovsky N, Lobigs M.

J Virol. 2013 Apr;87(8):4395-402. doi: 10.1128/JVI.03144-12. Epub 2013 Feb 6.

3.

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.

Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N.

J Gen Virol. 2010 Jun;91(Pt 6):1407-17. doi: 10.1099/vir.0.019190-0. Epub 2010 Feb 3.

4.

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection.

Honda-Okubo Y, Ong CH, Petrovsky N.

Vaccine. 2015 Sep 11;33(38):4892-900. doi: 10.1016/j.vaccine.2015.07.051. Epub 2015 Jul 29.

PMID:
26232344
5.

The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.

Shrestha B, Ng T, Chu HJ, Noll M, Diamond MS.

Vaccine. 2008 Apr 7;26(16):2020-33. doi: 10.1016/j.vaccine.2008.02.009. Epub 2008 Feb 20.

7.

Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice.

Takasaki T, Yabe S, Nerome R, Ito M, Yamada K, Kurane I.

Vaccine. 2003 Nov 7;21(31):4514-8.

PMID:
14575761
8.

Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.

Magnusson SE, Karlsson KH, Reimer JM, Corbach-Söhle S, Patel S, Richner JM, Nowotny N, Barzon L, Bengtsson KL, Ulbert S, Diamond MS, Stertman L.

Vaccine. 2014 Feb 7;32(7):800-8. doi: 10.1016/j.vaccine.2013.12.030. Epub 2013 Dec 28.

PMID:
24380682
9.

Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.

Lobigs M, Larena M, Alsharifi M, Lee E, Pavy M.

J Virol. 2009 Mar;83(6):2436-45. doi: 10.1128/JVI.02273-08. Epub 2008 Dec 24.

10.

Antibody responses induced by experimental West Nile virus infection with or without previous immunization with inactivated Japanese encephalitis vaccine in horses.

Shirafuji H, Kanehira K, Kamio T, Kubo M, Shibahara T, Konishi M, Murakami K, Nakamura Y, Yamanaka T, Kondo T, Matsumura T, Muranaka M, Katayama Y.

J Vet Med Sci. 2009 Jul;71(7):969-74.

11.

A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Pinto AK, Richner JM, Poore EA, Patil PP, Amanna IJ, Slifka MK, Diamond MS.

J Virol. 2013 Feb;87(4):1926-36. doi: 10.1128/JVI.02903-12. Epub 2012 Dec 5.

12.

Memory B cells: a proposed new immunological correlate for protective efficacy of Japanese encephalitis vaccine.

Konishi E.

Expert Rev Vaccines. 2013 Aug;12(8):871-3. doi: 10.1586/14760584.2013.814828. Epub 2013 Aug 14.

PMID:
23944374
13.

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.

Bielefeldt-Ohmann H, Prow NA, Wang W, Tan CS, Coyle M, Douma A, Hobson-Peters J, Kidd L, Hall RA, Petrovsky N.

Vet Res. 2014 Dec 17;45:130. doi: 10.1186/s13567-014-0130-7.

14.

Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.

Okamoto S, Yoshii H, Matsuura M, Kojima A, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y.

Clin Vaccine Immunol. 2012 Jan;19(1):17-22. doi: 10.1128/CVI.05412-11. Epub 2011 Nov 16.

15.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.

J Infect Dis. 2003 Oct 15;188(8):1213-30. Epub 2003 Oct 3.

16.

Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.

Li SH, Li XF, Zhao H, Jiang T, Deng YQ, Yu XD, Zhu QY, Qin ED, Qin CF.

Immunol Lett. 2011 Aug 30;138(2):156-60. doi: 10.1016/j.imlet.2011.04.003. Epub 2011 Apr 14.

PMID:
21515306
17.

Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.

Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L.

Vaccine. 2008 Oct 16;26(44):5590-4. doi: 10.1016/j.vaccine.2008.07.104. Epub 2008 Aug 30.

PMID:
18761388
18.

Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.

Ishikawa T, Widman DG, Bourne N, Konishi E, Mason PW.

Vaccine. 2008 May 23;26(22):2772-81. doi: 10.1016/j.vaccine.2008.03.010. Epub 2008 Mar 31.

PMID:
18433947
19.

Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.

Honda-Okubo Y, Barnard D, Ong CH, Peng BH, Tseng CT, Petrovsky N.

J Virol. 2015 Mar;89(6):2995-3007. doi: 10.1128/JVI.02980-14. Epub 2014 Dec 17.

20.

The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.

Yamshchikov G, Borisevich V, Kwok CW, Nistler R, Kohlmeier J, Seregin A, Chaporgina E, Benedict S, Yamshchikov V.

Vaccine. 2005 Sep 15;23(39):4785-92.

PMID:
15939510
Items per page

Supplemental Content

Write to the Help Desk